scholarly journals Prognostic Factors and Local Treatment Modalities of Small-Cell Carcinoma of the Cervix: An Analysis According to the International Federation of Gynecology and Obstetrics Stage [Corrigendum]

2020 ◽  
Vol Volume 12 ◽  
pp. 6239-6240
Author(s):  
Ru Huang ◽  
Qiyu Gan ◽  
Jingxin Cheng
Keyword(s):  
Prognostic Factors ◽  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Local Treatment ◽  
Small Cell ◽  
International Federation ◽  
Treatment Modalities ◽  
Gynecology And Obstetrics

scholarly journals The local treatment modalities in FIGO stage I‐II small‐cell carcinoma of the cervix are determined by disease stage and lymph node status

2016 ◽  
Vol 5 (6) ◽  
pp. 1108-1115 ◽  
Author(s):  
Juan Zhou ◽  
Hong‐Yi Yang ◽  
San‐Gang Wu ◽  
Zhen‐Yu He ◽  
Huan‐Xin Lin ◽  
...  
Keyword(s):  
Lymph Node ◽  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Local Treatment ◽  
Figo Stage ◽  
Small Cell ◽  
Stage I ◽  
Disease Stage ◽  
Treatment Modalities ◽  
Lymph Node Status

Detailed Analysis of Prognostic Factors in Primary Esophageal Small Cell Carcinoma

2014 ◽  
Vol 97 (6) ◽  
pp. 1975-1981 ◽  
Author(s):  
Wei-Wei Chen ◽  
Feng Wang ◽  
ShaoBin Chen ◽  
Luhua Wang ◽  
Chao Ren ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Cell Carcinoma ◽  
Detailed Analysis ◽  
Small Cell Carcinoma ◽  
Small Cell

Extrapulmonary small cell carcinoma: Prognostic factors, patterns of care, and overall survival

2020 ◽  
Vol 46 (9) ◽  
pp. 1596-1604 ◽  
Author(s):  
Steven F. Mandish ◽  
Jeremy T. Gaskins ◽  
Mehran B. Yusuf ◽  
Brendan P. Little ◽  
Neal E. Dunlap
Keyword(s):  
Overall Survival ◽  
Prognostic Factors ◽  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Small Cell ◽  
Patterns Of Care ◽  
Extrapulmonary Small Cell Carcinoma

Prognostic factors for small cell carcinoma of the lung

1988 ◽  
Vol 24 (3) ◽  
pp. 353-355 ◽  
Author(s):  
Ronald Feld ◽  
Gerrit Deboer ◽  
Uri Sagman
Keyword(s):  
Prognostic Factors ◽  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Small Cell

scholarly journals Survival outcomes and prognostic factors of primary small cell carcinoma of the esophagus

2021 ◽  
Vol 13 (5) ◽  
pp. 2790-2802
Author(s):  
Huikai Miao ◽  
Rongzhen Li ◽  
Dongni Chen ◽  
Jia Hu ◽  
Youfang Chen ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Small Cell ◽  
Survival Outcomes ◽  
Carcinoma Of The Esophagus

scholarly journals Radiotherapy for small cell carcinoma of the esophagus: outcomes and prognostic factors from a retrospective study

2019 ◽  
Vol 14 (1) ◽  
Author(s):  
Baoqing Chen ◽  
Han Yang ◽  
Huali Ma ◽  
Qiaoqiao Li ◽  
Bo Qiu ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Small Cell ◽  
Therapeutic Modality ◽  
Cancer Center ◽  
Lesion Length ◽  
Carcinoma Of The Esophagus ◽  
Kaplan Meier ◽  
Ecog Ps

Abstract Background Small cell carcinoma of the esophagus (SCCE) is characterized by its progressive feature and poor prognosis. There is no consensus on a standard therapeutic modality for SCCE. In this study, we aimed to characterize the outcomes of primary SCCE patients treated by radiation therapy as part of treatment and investigate prognostic factors. Methods We retrospectively analyzed the data of 42 SCCE patients who were treated by RT as part of treatment at the Sun Yat-sen University Cancer Center from 2001 to 2014. The Kaplan-Meier and log-rank method were used to analyze survival. Cox’s hazard regression model was applied to determine prognostic factors. Results Of the 42 enrolled patients, 25 had limited disease (LD) and 17 with extensive disease (ED). The overall response rate (CR + PR) was 60.0% (21/35). The median overall survival time (OS) for whole and LD group were 12.9 and 36.8 months. The 1-, 3- and 5-year OS rates of the whole cohort were 64.9, 31.3, and 13.9%, respectively. OS was significantly longer in patients with ECOG performance score (ECOG PS) < 2 (p = 0.001), lesion length ≤ 5 cm (p = 0.001), and LD (p = 0.049). In the patients with LD, multivariate analysis indicated that combined with chemotherapy (P = 0.046) and higher radiation dose (P = 0.027) predicted better prognosis in OS. The overall rate of grade 3–4 toxicities in the whole cohort was 37.5%. In total, 65% (17/26) patients with recurrent disease died with the metastasis with or without the primary recurrence. Conclusion RT was one of the effective and safe treatments for locoregional control of SCCE. Lower ECOG PS score, shorter lesion length, treated with chemotherapy, and a higher dose of RT were identified as favorable independent prognostic factors.

Sign in / Sign up

Export Citation Format

Share Document